Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
HERON THERAPEUTICS, INC. /DE/ (HRTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
16 Nov 2023
Collard Craig A
Chief Executive Officer, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
186,496
+411%
150,000
$0.92
$137,970.00
BUY
16 Nov 2023
Duarte Ira
EVP, Chief Financial Officer, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
85,000
+100%
85,000
$0.89
$75,599.00
BUY
16 Nov 2023
Forbes William P
EVP, Chief Development Officer, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
54,000
+1250%
50,000
$0.94
$46,995.00
SELL
3 May 2022
MANHARD KIMBERLY
EVP, Drug Development, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
10,872
-12%
1,504
$4.76
$7,153.63
SELL
21 Dec 2021
Christian Waage
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
3,200
-8%
300
$9.73
$2,920.35
SELL
21 Dec 2021
Johnson Craig A
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
2,840
-8%
250
$9.73
$2,431.93
SELL
21 Sep 2021
Christian Waage
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
3,500
-7%
300
$12.31
$3,691.95
SELL
21 Sep 2021
Johnson Craig A
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
3,090
-7%
250
$12.30
$3,074.10
SELL
21 Jun 2021
Christian Waage
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
3,800
-7%
300
$15.20
$4,559.19
SELL
21 Jun 2021
Johnson Craig A
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
3,340
-6%
250
$15.20
$3,800.60
SELL
3 May 2021
MANHARD KIMBERLY
EVP, Drug Development, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
1,634
-48%
1,529
$17.66
$27,008.72
SELL
15 Apr 2021
Christian Waage
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
4,100
-6%
300
$17.51
$5,253.78
SELL
6 Apr 2021
Johnson Craig A
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
3,590
-6%
250
$17.22
$4,305.20
SELL
31 Mar 2021
Ashley Hinson Arenholz
Congressman (House)
HERON THERAPEUTICS, INC. /DE/
(HRTX)
N/A
N/A
N/A
$1,001 - $15,000
SELL
13 Jan 2021
Szekeres David Leslie
EVP, Chief Operating Officer, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
827
$18.09
$14,960.18
SELL
8 Jan 2021
Szekeres David Leslie
EVP, Chief Operating Officer, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
3,571
$19.66
$70,219.43
SELL
22 Dec 2020
MANHARD KIMBERLY
EVP, Drug Development, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
10,000
$20.00
$200,000.00
SELL
1 May 2020
MANHARD KIMBERLY
Executive VP, Drug Development, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
1,158
$13.97
$16,175.76
SELL
29 Nov 2019
MANHARD KIMBERLY
Executive VP, Drug Development, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
24,000
$26.00
$624,000.00
BUY
4 Oct 2019
TANG KEVIN C
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
5,799,810
+5%
285,714
$17.50
$4,999,995.00
BUY
3 Oct 2019
Quart Barry D
Chief Executive Officer, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
94,652
+5%
4,571
$17.50
$79,992.50
BUY
3 Oct 2019
POYHONEN JOHN
EVP, Chief Commercial Officer, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
18,143
+39%
5,143
$17.50
$90,002.50
BUY
22 May 2019
POYHONEN JOHN
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
13,000
+30%
3,000
$17.55
$52,650.00
BUY
15 May 2019
Christian Waage
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
1,400
+100%
1,400
$18.04
$25,261.74
SELL
1 May 2019
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
1,109
$18.86
$20,918.07
SELL
2 Nov 2018
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
494
$30.62
$15,124.95
SELL
1 Oct 2018
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
6,000
$32.07
$192,433.20
SELL
12 Sep 2018
TANG KEVIN C
Director, 10% Owner
HERON THERAPEUTICS, INC. /DE/
(HRTX)
5,830,215
-31%
2,695,000
$35.75
$96,346,250.00
SELL
2 Jul 2018
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
100
-98%
6,000
$37.53
$225,178.66
SELL
2 Jul 2018
HOFFMAN ROBERT
CFO & SVP, Finance, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
2,340
-92%
30,000
$38.17
$1,145,230.20
SELL
29 Jun 2018
Rosen Robert
President, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
6,040
-97%
225,000
$38.98
$8,769,818.00
SELL
21 Jun 2018
Quart Barry D
Chief Executive Officer, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
69,600
-41%
50,000
$39.05
$1,952,500.00
BUY
29 Mar 2018
TANG KEVIN C
Director, 10% Owner
HERON THERAPEUTICS, INC. /DE/
(HRTX)
8,525,215
+2%
192,308
$26.00
$5,000,008.00
SELL
19 Mar 2018
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
18,000
$30.00
$540,000.00
SELL
19 Mar 2018
Quart Barry D
Chief Executive Officer, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
67,993
-59%
100,000
$29.75
$2,975,000.00
SELL
14 Mar 2018
Quart Barry D
Chief Executive Officer, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
67,993
-59%
100,000
$24.75
$2,475,000.00
SELL
10 Jan 2018
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
7,584
$20.00
$151,680.00
SELL
24 Apr 2017
MANHARD KIMBERLY
Executive VP, Drug Development, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
0
-100%
21,542
$15.33
$330,262.56
BUY
19 Jan 2017
TANG KEVIN C
Director, 10% Owner
HERON THERAPEUTICS, INC. /DE/
(HRTX)
8,332,907
+41%
2,459,016
$12.20
$29,999,994.00
BUY
19 Jan 2017
POYHONEN JOHN
Director
HERON THERAPEUTICS, INC. /DE/
(HRTX)
10,000
+100%
10,000
$12.20
$122,000.00
SELL
10 Aug 2016
Rosen Robert
President & CCO, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
15,040
-86%
100,000
$23.30
$2,329,894.80
SELL
19 Apr 2016
Rosen Robert
President, Director, Officer
HERON THERAPEUTICS, INC. /DE/
(HRTX)
2,640
-98%
200,000
$23.23
$4,646,422.00
Home